Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exerts neuroprotective effect via inhibition of neuronal apoptosis in vitro

Phytotherapy Research

Volumn 22, Issue 6, 2008, Pages 846-850

  Yu, Xue Qing ^a   Xue, Charlie Changli ^b   Zhou, Zhi Wei ^a   Li, Chun Guang ^b   Zhou, Shu Feng ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Division of Chinese Medicine   (Australia)

^c WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Apoptosis; Bcl 2; Danshen; Neuron; Tanshinone IIB

Indexed keywords

CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; STAUROSPORINE; TANSHINONE; TANSHINONE IIB;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; IN VITRO STUDY; ISCHEMIC HEART DISEASE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SALVIA MILTIORRHIZA; STROKE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IN SITU NICK-END LABELING; NEURONS; PHENANTHRENES; PREGNANCY; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; STAUROSPORINE;

RATTUS; SALVIA MILTIORRHIZA;

EID: 46849117754     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2404     Document Type: Article

References (25)

1. Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. 2005. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2: 554-571.
2. Chen Q, Chao R, Chen H et al. 2005. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer 114: 675-682.
3. Choi DW. 1988. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 11: 465-469.
4. Cory S, Huang DC, Adams JM. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
5. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
6. Gu M, Zhang G, Su Z, Ouyang F. 2004. Identification of major active constituents in the fingerprint of Salvia miltiorrhiza Bunge developed by high-speed counter-current chroma-tography. J Chromatogr A 1041: 239-243.
7. Jacobson MD, Burne JF, King MP et al. 1993. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369.
8. Jantas-Skotniczna D, Kajta M, Lason W. 2006. Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal cultures. Brain Res 1069: 145-153.
9. Lam BY, Lo AC, Sun X et al. 2003. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10: 286-291.
10. Li Y, Johnson N, Capano M, Edwards M, Crompton M. 2004. Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis. Biochem J 383: 101-109.
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
12. Mattson MP, Kater SB. 1988. Isolated hippocampal neurons in cryopreserved long-term cultures: development of neuro-architecture and sensitivity to NMDA. Int J Dev Neurosci 6: 439-452.
13. Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. 2003. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 23: 4798-4802.
14. Petit A, Kawarai T, Paitel E et al. 2005. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280: 34025-34032.
15. Pratesi G, Perego P, Zunino F. 2001. Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy. Biochem Pharmacol 61: 381-386.
16. 2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J Neurochem 68: 1679-1685.
17. Rametti A, Esclaire F, Yardin C, Terro F. 2004. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis. J Biol Chem 279: 54518-54528.
18. Schwartzman RA, Cidlowski JA. 1993. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 14: 133-151.
19. Sztriha LK, Sas K, Vecsei L. 2005. Aspirin resistance in stroke: 2004. J Neurol Sci 229-230: 163-169.
20. van der Worp HB, van Gijn J. 2007. Clinical practice. Acute ischemic stroke. N Engl J Med 357: 572-579.
21. Wu B, Liu M, Zhang S. 2004. Dan Shen agents for acute ischaemic stroke. Cochrane Database Syst Rev. CD004295.
22. Yu XY, Lin SG, Zhou ZW et al. 2007. Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exhibits neuro-protective activity in experimentally stroked rats. Neurosci Lett 417: 261-265.
23. Zhang HY, Tang XC. 2003. Huperzine A attenuates the neurotoxic effect of staurosporine in primary rat cortical neurons. Neurosci Lett 340: 91-94.
24. Zhu Y-P. 1998. Chinese Materia Medica: Chemistry, Pharmacology and Applications.: Harwood Academic Publishers: Amsterdam, The Netherlands.
25. Zhu YZ, Huang SH, Tan BK et al. 2004. Antioxidants in Chinese herbal medicines: a biochemical perspective. Nat Prod Rep 21: 478-489.